Zometa blev undersøgt hos mere end 3 000 patienter med knoglemetastaser for at studere lægemidlets virkning på forebyggelsen af knogleskader.
Reproduction is authorised provided the source is acknowledged. was the proportion of patients who developed at least one new ‘ skeletal event ’ over 13 months.